JCJustin Corcoran

Justin Corcoran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Justin Corcoran has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cardiovascular toxicity associated with supplement use

    by Justin Corcoran

    Supplement use is prevalent and appears to be increasing over time. In the United States, regulation by the Food and Drug Administration is limited largely to post-marketing surveillance, raising safety concerns. A variety of supplements have been associated with cardiovascular toxicity, which can occur via adulteration, substitution, or as a result of intrinsic toxicity of the supplement. Cardiovascular toxicity due to supplement use may arise via several different mechanisms, and has been reported with supplements that act as central nervous system stimulants, via poisoning of cardiac ion channels, as a result of cardioactive steroids, and by modulation of the endocrine system. Supplements that act as central nervous system stimulants include those that act directly on adrenoreceptors or indirectly via the release of catecholamines, and include substances such as ephedra, synephrine, and yohimbine. Adverse effects vary depending on the agent and include tachycardia, hypertension, hyperthermia, myocardial infarction, and cardiac arrest. Poisoning of cardiac voltage-gated sodium channels has been reported with supplements that contain or are contaminated with aconitine or grayanotoxins and cause wide complex dysrhythmias. Inhibition of cardiac myocyte voltage-gated potassium channels is associated with berberine, leading to prolongation of the QT interval and polymorphic ventricular tachycardia. Cardioactive steroids derived from yellow oleander are implicated in serious toxicity and death associated with the weight loss product "Nuez de la India" in what appears to be an inadvertent substitution error. Animal-derived cardioactive steroids from the Bufo spp. of toad used as an aphrodisiac also cause clinically significant cardiac toxicity and death. Supplemental use of black licorice induces hypokalemia, and is associated with the development of torsade de pointes. Clinically significant cardiovascular toxicity associated with supplement use is a fortunately rare phenomenon that can occur via multiple mechanisms. Clinicians should maintain awareness that supplements may produce serious and sometimes life-threatening cardiovascular poisoning.


  • Ivabradine exposures reported to United States poison centers 2015–2023

    by Laura Szczesniak, Stephen Thornton, Ryan Feldman, Justin Corcoran

    Ivabradine was approved for use in the United States in 2015 for the management of heart failure. It acts through inhibition of sodium channels found in cardiac myocytes (the "funny" pacemaker current, If), which reduces heart rate without significantly affecting inotropy. We queried the National Poison Data System® for reported ivabradine exposures from April 15, 2015-December 31, 2023. Age was stratified into child (0-5 years), adolescent (6-17 years), adult (18-64 years) and geriatric (65+ years). Other descriptive statistics gathered included patient sex, management site, and medical outcome as coded by America's Poison Centers®. There were 240 ivabradine exposures, with 55.0% managed on-site and not transferred to a healthcare facility. The most common reported symptom was bradycardia, reported in 36 patients (15.1%). There were 139 cases that were followed to a known outcome. Within this cohort, 60%, 14%, and 27% of patients suffered no effect, minor effect, or moderate effect, respectively. Exposures in children comprised 18.8% of cases; none required intervention. Intentional self-harm exposures comprised 17.1% of all cases and were more likely to have worse outcomes. Five adult patients received intensive therapy (endotracheal intubation, vasopressors, cardiac pacing, hemodialysis). There were no reported deaths from ivabradine exposure. This study has limitations. First, our data source was limited by being retrospective and incomplete; we could only study the information that was reported to poison centers, and exposures were not confirmed by laboratory testing. It is possible that cases without further follow-up had other treatments and clinical effects not reported here. Finally, reports to poison centers likely underestimate the true number of ivabradine exposures. Adults with unintentional, asymptomatic exposures to ivabradine may be candidates for home monitoring. In ivabradine exposures refractory to medical management, clinicians should consider cardiac pacing or other supportive measures as a temporizing measure.

  • Trimeresurus insularis (blue Indonesian pit viper) envenomation treated with Thai green pit viper antivenom

    by Ryan Feldman, Matthew Stanton, Justin Corcoran, Kristin Bialkowski, Jillian Theobald, David Gummin


  • Outcomes of pediatric ingestions of alcohol-based hand sanitizers during the COVID-19 pandemic

    by Justin Corcoran, Ryan Feldman, Jillian Theobald

    In July 2020, an outbreak of methanol-contaminated hand sanitizers in the United States prompted our regional poison center to implement a more conservative triage guideline for hand sanitizer exposures. All pediatric hand sanitizer ingestions of more than a "taste" were referred to a healthcare facility for assessment. We then evaluated the effect of this change on identifying patients with methanol poisoning. This was a single-center, retrospective review of pediatric (<19 years) hand sanitizer ingestions reported to our poison center from May 1, 2020 through January 28, 2022. Methanol and ethanol concentrations were collected if available. During the study period, we received 801 calls regarding hand sanitizer exposure, of which 140 children were referred to a healthcare facility for hand sanitizer ingestions. Of those, 88 (63%) had methanol and/or ethanol concentrations measured. No child had a detectable methanol concentration, 78 had ethanol testing, and 12 had a detectable ethanol concentration. In this sample, no patient tested had a detectable methanol concentration. Children who consumed enough to have a detectable ethanol concentration were symptomatic or had an intentional ingestion. Asymptomatic children with unintentional ingestion of hand sanitizer were at low risk for methanol toxicity.


  • Open Access

    In Reply: “On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy”

    by Justin N. Corcoran, Katherine J. Jacoby, Travis D. Olives, Stacey A. Bangh, Jon B. Cole


  • Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report

    by Justin N. Corcoran, Katherine J. Jacoby, Travis D. Olives, Stacey A. Bangh, Jon B. Cole

    Introduction Overdoses of beta-adrenergic antagonists and calcium channel antagonists represent an uncommonly encountered but highly morbid clinical presentation. Potential therapies include fluids, calcium salts, vasopressors, intravenous lipid emulsion, methylene blue, and high-dose insulin. Although high-dose insulin is commonly used, the kinetics of insulin under these conditions are unknown. Case Report We present a case of a 51-year-old male who sustained a life-threatening overdose after ingesting approximately 40 tablets of a mixture of amlodipine 5 mg and metoprolol tartrate 25 mg. Due to severe bradycardia and hypotension, he was started on high-dose insulin (HDI) therapy; this was augmented with epinephrine. Despite the degree of his initial shock state, he ultimately recovered, and HDI was discontinued. Insulin was infused for a total of approximately 37 hours, most of which was dosed at 10 U/kg/hour; following discontinuation, serial serum insulin levels were drawn and remained at supraphysiologic levels for at least 24 hours and well above reference range for multiple days thereafter. Conclusion The kinetics of insulin following discontinuation of high-dose insulin therapy are largely unknown, but supraphysiologic insulin levels persist for some time following therapy; this may allow for simple discontinuation rather than titration of insulin at the end of therapy. Dextrose replacement is frequently needed; although the duration is often difficult to predict, prolonged infusions may not be necessary.


  • Articles You Might Have Missed

    by Justin N. Corcoran, Robert C. Pueringer, Chris N. Sweat, Samuel J. Stellpflug